Richard Adams

Has grant

Professor

Cardiff University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Richard Adams is a faculty member at Cardiff University in the United Kingdom. His research primarily focuses on cancer treatment and outcomes, with recent publications addressing topics such as neoadjuvant treatment for rectal cancer, the use of immune checkpoint inhibitors in metastatic colorectal cancer, and the implications of national radiotherapy guidelines. His work contributes significantly to the understanding and advancement of therapeutic strategies in oncology.

Recent Grants

Grant: Close

Wales Cancer Biobank

Open Date: 2020-10-01

Close Date: 2023-09-01

Grant: Close

Wales Cancer Research Centre

Open Date: 2020-10-01

Close Date: 2023-09-01

Grant: Close

ARIEL: A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer with wild-type RAS and right primary tumour location

Open Date: 2020-10-01

Close Date: 2026-03-31

Grant: Close

VALTIVE1: validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors

Open Date: 2020-03-01

Close Date: 2023-12-01

Grant: Close

Centre for Trials Research Cardiff - HCRW

Open Date: 2019-10-01

Close Date: 2024-09-01

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (26)

Daniel McAuley

Professor - Concultant, Intensive Care Medicine

The Queen's University Belfast

UNITED KINGDOM

Richard Adams

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Response to Biologics in Patients With Early-Onset Treatment-Naïve Metastatic Colorectal Cancer—An Aide et Recherche en Cancérologie Digestive Database Analysis

Neoadjuvant Treatment of Rectal Cancer: A Repeat UK-wide Survey After Implementation of National Intensity Modulated Radiotherapy Guidance

Reconsidering the Role of Radiotherapy for Inoperable Gastric Cancer: A Systematic Review of Gastric Radiotherapy Given With Definitive and Palliative Intent

The Impact of National Radiotherapy Guidelines: The UK Anal Cancer Story

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT

Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation

Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against

International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set

Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

Early switch to oral antibiotic therapy in patients with low risk neutropenic sepsis (EASI-SWITCH): A randomized non-inferiority trial

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial

Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database

Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study

A Road Map for Designing Phase I Clinical Trials of Radiotherapy–Novel Agent Combinations

Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT

Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

Collaborators (26)

Daniel McAuley

Matthew Seymour

Philip Quirke

Séan Micheal O'Cathail

David J. Fisher

Christopher Lieu

Emma Hall

Robert Morgan

Maria Andreia Hawkins

Lisette Nixon

Hayley Anne Hutchings

John R. Zalcberg

Ian Chau

Louise Brown

Samantha Hinsley

Emiliano Spezi

Leslie Samuel

Timothy Stanley Maughan

Ane L Appelt

Anthony Byrne

Chris Hurt

Angela Casbard

Anna Dorothea Wagner

Eric Van Cutsem

David Sebag-Montefiore

Catherine Hanna

Make your next move.